Red blood cell alloimmunization from an African perspective

Current Opinion in Hematology

Volumn 17, Issue 6, 2010, Pages 565-570

  Natukunda, Bernard ^a   Brand, Anneke ^b   Schonewille, Henk ^b  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Africa; alloimmunization; hemolytic disease of the fetus and newborn; red blood cell transfusion

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD GROUP E ANTIGEN; ERYTHROCYTE ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ANTIBODY SPECIFICITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RH; BLOOD GROUP TYPING; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HEMOLYTIC ANEMIA; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOPROPHYLAXIS; MALAWI; NEGRO; NEWBORN HEMOLYTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; UGANDA;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; ERYTHROCYTES; HUMANS; ISOANTIBODIES;

EID: 78049265847     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833ec54b     Document Type: Review

References (47)

1. Wang L-Y, Liang D-C, Liu H-C, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006; 16:200-203.
2. Ameen R, Al Shemmari S, Al-Bashir A. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion 2009; 49:1649-1654.
3. Reviron D, Dettori I, FerreraV, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005; 45:956-959.
4. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006; 132:374-378.
5. Picard C, Frassati C, Basire A, et al. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a southern European population. Transfusion 2009; 49:2412-2417.
6. Hoppe C, Klitz W, Vichinsky E, Styles L. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 2009; 84:462-464.
7. Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46:630-635.
8. Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009; 49:453-457.
9. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112:2546-2553.
10. Kang V, Tang L, Li X, et al. Identification and characterization of Foxp3(+) gammadeltaT cells in mouse and human. Immunol Lett 2009; 125:105-113.
11. Chou ST, Westhoff CM. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease. Hematology Am Soc Hematol Educ Program 2009:178-184.
12. Natukunda B, Schonewille H, Smit Sibinga CT. Assessment of the clinical transfusion practice at a regional referral hospital in Uganda. Transfus Med 2010; 20:134-139.
13. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86:480-487.
14. Ong'echa JM, Keller CC, Were T, et al Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. Am J Trop Med Hyg 2006 74 376-385.
15. Otieno RO, Ouma C, Ong'echa JM, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20:275-280.
16. Obonyo CO, Vulule J, Akhwale WS, Grobbee DE. In-hospital morbidity and mortality due to severe malarial anemia in western Kenya. Am J Trop Med Hyg 2007; 77 (6 Suppl):23-28.
17. Calis JC, van Hensbroek MB, de Haan RJ, et al. HIV-associated anemia in children: a systematic review from a global perspective. AIDS 2008; 22:1099-1112.
18. Zakariah AY, AlexanderS, van Roosmalen J, et al. Reproductive age mortality survey (RAMOS) in Accra, Ghana. Reprod Health 2009; 6:7-12.
19. Tapko JB, Mainuka P, Diarra-Nama AJ. Status of blood safety in the WHO African region. Report of the 2006 survey. http://www.afro.who.int/en/ divisions-a-programmes/dsd/health-tech nologies-a-laboratories.html. [Accessed 1 2 May 2010]
20. Allain JP. Volunteer safer than replacement donor blood: a myth revealed by evidence. ISBT Science Series 2010; 5:169-175.
21. Allain JP, Sardokie F, AsenseMensah K, Owusu-Ofori S. Relative safety of first-time volunteer and replacement donors in west Africa. Transfusion 2010; 50:340-343.
22. Ahmed SG. A strategic approach to the problems of providing rhesus D-negative blood transfusion in geographic areas with low RhD negativity: a Nigerian perspective. Transfus Med Rev 2010; 24:140-146.
23. Kajja I, Bimenya G, Smit Sibinga C. The interface between blood preparation and use in Uganda. Vox Sang 2010; 98 (3 Pt 1):e257-e262.
24. Mbanya D, Binam F, Kaptue L. Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation. Int J Infect Dis 2001; 5:70-73.
25. Arewa OP, Akinola NO, Salawu L. Blood transfusion reactions: evaluation of 462 transfusions at a tertiary hospital in Nigeria. Afr J MedSci 2009; 38:143-148.
26. de Graaf JD, Kajja I, Bimenya GS, et al. Bedside practice of blood transfusion in a large teaching hospital in Uganda: an observational study. Asian J Transfus Sci 2009; 3:60-65.
27. Natukunda B, Schonewille H, van de Watering L, Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010; 98:167-171.
28. Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmu-nization in sickle cell disease patients in Uganda. Transfusion 2010; 50:20-25.
29. M'baya B, MfuneT, Mogombo E, et al The prevalence of red cell antigens and antibodies in Malawi. Transfus Med 2010 20 196-199.
30. Issitt PD. Race-related red cell alloantibody problems. Br J Biomed Sci 1994; 51:158-167.
31. Reid ME, Lomas-Francis C. The blood group antigen facts book. 2nd ed. San Diego, USA: Academic Press Inc; 2004.
32. Cserti CM, Dzik WH. The ABO blood group system and Plasmodium falciparum malaria. Blood 2007; 110:2250-2258.
33. Anstee DJ. The relation between blood groups and disease. Blood 2010; 115:4635-4643.
34. Touinssi M, Chapel-Fernandes S, Granier T, et al. Molecular analysis of inactive and active RHD alleles in native Congolese cohorts. Transfusion 2009; 49:1353-1360.
35. Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13-19.
36. Issitt PD, Anstee DJ, editors. Applied blood group serology. 4th ed. Durham (NC): Montgomery Scientific Publications; 1998. pp. 439-460.
37. MoshaD, Poulsen A, Reyburn H, et al. Quality of paediatric blood transfusions in two district hospitals in Tanzania: a cross-sectional hospital based study. BMC Pediatr 2009; 9:51-56.
38. Saving Babies 2006-2007, Sixth report on perinatal care in South Africa. MRC Research Unit for Maternal and Infant Healthcare Strategies, PPIP Users and the Saving Babies Technical Task Team. The MRC Unit for Maternal and Infant Healthcare Strategies Kalafong Hospital, Pretoria. www.ppip.co.za/downloads/ Saving%20babies%202006-7.pdf. [Accessed 26 May 2010]
39. Aniebue UU, Aniebue PN. A risk assessment for pregnancy using the World Health Organization classifying form in primary health-care facilities in Enugu, Nigeria. Trop Doct 2008; 38:135-137.
40. Belinga S, Ngo Sack F, Bilong C, et al. High prevalence of anti-D antibodies among women of childbearing age at Centre Pasteur of Cameroon. Afr J Reprod Health 2009; 13:47-52.
41. Wagner FF, Moulds JM, Tounkara A, et al. RHD allele distribution in Africans of Mali. BMC Genet 2003; 4:14-20.
42. Denomme GA, Wagner FF, Fernandes BJ, et al. Partial D, weak D types, and novel RHD alleles among 33864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005; 45:1554-1560.
43. Cakana AZ, Ngwenya L. Is antenatal antibody screening worthwhile in the Zimbabwean population? Cent Afr J Med 2000; 46:38-41.
44. Kotila TR, Odukogbe AA, Okunlola MA, et al. The pregnant Rhesus negative Nigerian woman. Niger Postgrad Med J 2005; 12:305-307.
45. Mandisodza AR, MangoyiG,MusekiwaZ,et al. Incidenceofhaemolytic disease of the newborn in Harare, Zimbabwe. West Afr J Med 2008; 27:29-31.
46. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000; 40:1127-1131.
47. Reverberi R. The persistence of red cell alloantibodies. Blood Transfus 2008; 6:225-234.